| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |